SCHEMBL22495263

SCHEMBL22495263

N#Cc1ccc(N2CCN(c3ccc(NC(=O)c4ccc(OCC(O)CF)cc4)cc3)CC2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.54
MEN1 O00255 3/20 0.54
MAPT P10636 12/20 0.53
ALDH1A1 P00352 7/20 0.53
HSD17B10 Q99714 4/20 0.53
ALOX15 P16050 2/20 0.53
HPGD P15428 2/20 0.53
TSHR P16473 1/20 0.53
TAAR1 Q96RJ0 1/20 0.53
SMN1; SMN2 Q16637 5/20 0.52
KDM4E B2RXH2 3/20 0.52
LMNA P02545 2/20 0.52
USP2 O75604 2/20 0.51
HIF1A Q16665 1/20 0.51
NPSR1 Q6W5P4 1/20 0.50
RXFP1 Q9HBX9 1/20 0.50
RAB9A P51151 2/20 0.49
NPC1 O15118 1/20 0.49
KCNH2 Q12809 1/20 0.48
NR4A1 P22736 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31504253 1.00 KMT2A (0.54) KMT2AMEN1MAPTALDH1A1HSD17B10
SCHEMBL22495286 0.91 PANK3 (0.48) KMT2AMEN1MAPTALDH1A1HSD17B10
SCHEMBL31504187 0.91 PANK3 (0.48) KMT2AMEN1MAPTALDH1A1HSD17B10
SCHEMBL22495255 0.85 MAPT (0.62) KMT2AMEN1MAPTALDH1A1HSD17B10
SCHEMBL31504277 0.83 KMT2A (0.54) KMT2AMEN1MAPTALDH1A1HSD17B10
SCHEMBL22495397 0.83 KMT2A (0.54) KMT2AMEN1MAPTALDH1A1HSD17B10
SCHEMBL22495415 0.83 MAPT (0.55) KMT2AMEN1MAPTALDH1A1HSD17B10
SCHEMBL31504241 0.83 MAPT (0.55) KMT2AMEN1MAPTALDH1A1HSD17B10
SCHEMBL22495350 0.82 KMT2A (0.48) KMT2AMEN1MAPTALDH1A1HSD17B10
SCHEMBL31504293 0.82 KMT2A (0.48) KMT2AMEN1MAPTALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3728234-B1 RADIOLABELED COMPOUNDS HOFFMANN LA ROCHE (CH) 2025-05-14 EP claimed
US-11541132-B2 Radiolabeled compounds HOFFMANN-LA ROCHE INC. (US) 2023-01-03 US claimed
US-20200316232-A1 RADIOLABELED COMPOUNDS HOFFMANN-LA ROCHE INC. (US) 2020-10-08 US claimed
CN-111511732-A Radiolabelled compounds 豪夫迈·罗氏有限公司 2020-08-07 CN claimed
EP-3728234-B1 RADIOLABELED COMPOUNDS HOFFMANN LA ROCHE (CH) 2025-05-14 EP disclosed
US-11541132-B2 Radiolabeled compounds HOFFMANN-LA ROCHE INC. (US) 2023-01-03 US disclosed
US-11541132-B2 Radiolabeled compounds HOFFMANN-LA ROCHE INC. (US) 2023-01-03 US disclosed
US-20200316232-A1 RADIOLABELED COMPOUNDS HOFFMANN-LA ROCHE INC. (US) 2020-10-08 US disclosed
US-20200316232-A1 RADIOLABELED COMPOUNDS HOFFMANN-LA ROCHE INC. (US) 2020-10-08 US disclosed
CN-111511732-A Radiolabelled compounds 豪夫迈·罗氏有限公司 2020-08-07 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11541132-B2 Radiolabeled compounds SNCA, APP, BACE1 KMT2A 4463/4885MEN1 311/4885MAPT 16/4885
US-20200316232-A1 RADIOLABELED COMPOUNDS SNCA, APP, BACE1 KMT2A 4496/4885MEN1 326/4885MAPT 17/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.